Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study

AIMS: Cysteamine bitartrate (Cystagon®) is the approved treatment for cystinosis. Poor compliance and patient outcome may occur because the drug needs to be taken every 6 h and in some patients causes gastrointestinal symptoms due to hypergastrinaemia. A formulation of cysteamine requiring twice dai...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Gangoiti, Jon A, Fidler, Meredith, Cabrera, Betty L, Schneider, Jerry A, Barshop, Bruce A, Dohil, Ranjan
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2010
Teme:
Pharmacokinetics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2949910/
https://ncbi.nlm.nih.gov/pubmed/20716238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03721.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items